INVO Bioscience, Inc. (INVO)
USD 0.83
(-2.0%)
USD 0.83
(-2.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 8.45 Million USD | 228.32% |
| 2022 | 2.57 Million USD | 172.28% |
| 2021 | -3.56 Million USD | 61.8% |
| 2020 | -9.32 Million USD | -1093.51% |
| 2019 | -781.11 Thousand USD | -526.03% |
| 2018 | 183.34 Thousand USD | -42.13% |
| 2017 | 316.85 Thousand USD | 58.26% |
| 2016 | 200.2 Thousand USD | 173.85% |
| 2015 | -271.11 Thousand USD | -151.91% |
| 2014 | 522.26 Thousand USD | 14.32% |
| 2013 | 456.86 Thousand USD | -2.32% |
| 2012 | 467.69 Thousand USD | -3.94% |
| 2011 | 486.89 Thousand USD | 8.18% |
| 2010 | 450.06 Thousand USD | 247.5% |
| 2009 | 129.51 Thousand USD | -0.94% |
| 2008 | 130.74 Thousand USD | 3039.43% |
| 2007 | -4448.00 USD | 67.74% |
| 2006 | -13.78 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 4.43 Million USD | -24.91% |
| 2024 Q1 | 5.9 Million USD | -30.13% |
| 2023 FY | 8.45 Million USD | 228.32% |
| 2023 Q3 | 7.75 Million USD | 54.33% |
| 2023 Q4 | 8.45 Million USD | 9.04% |
| 2023 Q2 | 5.02 Million USD | 562.62% |
| 2023 Q1 | 757.86 Thousand USD | -70.56% |
| 2022 Q3 | 1.67 Million USD | 3115.27% |
| 2022 Q4 | 2.57 Million USD | 53.92% |
| 2022 FY | 2.57 Million USD | 172.28% |
| 2022 Q1 | -1.77 Million USD | 50.28% |
| 2022 Q2 | 52.01 Thousand USD | 102.94% |
| 2021 Q1 | -8 Million USD | 14.14% |
| 2021 Q2 | -4.94 Million USD | 38.27% |
| 2021 FY | -3.56 Million USD | 61.8% |
| 2021 Q4 | -3.56 Million USD | -21.24% |
| 2021 Q3 | -2.93 Million USD | 40.55% |
| 2020 Q1 | 152.54 Thousand USD | 119.53% |
| 2020 FY | -9.32 Million USD | -1093.51% |
| 2020 Q3 | -56.35 Thousand USD | 86.38% |
| 2020 Q2 | -413.66 Thousand USD | -371.18% |
| 2020 Q4 | -9.32 Million USD | -16442.58% |
| 2019 Q2 | -2.26 Million USD | 19.59% |
| 2019 Q3 | -1.59 Million USD | 29.36% |
| 2019 FY | -781.11 Thousand USD | -526.03% |
| 2019 Q4 | -781.11 Thousand USD | 51.12% |
| 2019 Q1 | -2.81 Million USD | -1634.3% |
| 2018 Q1 | 307.2 Thousand USD | -3.04% |
| 2018 FY | 183.34 Thousand USD | -42.13% |
| 2018 Q4 | 183.34 Thousand USD | 220.4% |
| 2018 Q3 | -152.28 Thousand USD | 56.39% |
| 2018 Q2 | -349.2 Thousand USD | -213.67% |
| 2017 Q1 | 302.96 Thousand USD | 51.32% |
| 2017 Q3 | 307.35 Thousand USD | -5.29% |
| 2017 Q2 | 324.53 Thousand USD | 7.12% |
| 2017 Q4 | 316.85 Thousand USD | 3.09% |
| 2017 FY | 316.85 Thousand USD | 58.26% |
| 2016 FY | 200.2 Thousand USD | 173.85% |
| 2016 Q3 | 94.01 Thousand USD | 191.52% |
| 2016 Q1 | -202.43 Thousand USD | 25.33% |
| 2016 Q2 | -102.72 Thousand USD | 49.26% |
| 2016 Q4 | 200.2 Thousand USD | 112.96% |
| 2015 FY | -271.11 Thousand USD | -151.91% |
| 2015 Q4 | -271.11 Thousand USD | 0.0% |
| 2015 Q1 | 18.62 Thousand USD | 0.0% |
| 2014 FY | 522.26 Thousand USD | 14.32% |
| 2013 FY | 456.86 Thousand USD | -2.32% |
| 2012 FY | 467.69 Thousand USD | -3.94% |
| 2011 Q3 | 128.24 Thousand USD | -74.09% |
| 2011 Q1 | 451.36 Thousand USD | 0.29% |
| 2011 Q4 | 486.89 Thousand USD | 279.67% |
| 2011 Q2 | 494.89 Thousand USD | 9.64% |
| 2011 FY | 486.89 Thousand USD | 8.18% |
| 2010 Q4 | 450.06 Thousand USD | -5.0% |
| 2010 Q3 | 473.76 Thousand USD | 27.74% |
| 2010 Q2 | 370.89 Thousand USD | 56.89% |
| 2010 Q1 | 236.39 Thousand USD | 82.53% |
| 2010 FY | 450.06 Thousand USD | 247.5% |
| 2009 FY | 129.51 Thousand USD | -0.94% |
| 2009 Q4 | 129.51 Thousand USD | 707.74% |
| 2009 Q1 | 211.71 Thousand USD | 61.93% |
| 2009 Q3 | 16.03 Thousand USD | -93.16% |
| 2009 Q2 | 234.38 Thousand USD | 10.71% |
| 2008 Q2 | 7686.00 USD | 8.47% |
| 2008 Q1 | 7086.00 USD | 259.31% |
| 2008 Q4 | 130.74 Thousand USD | 29815.0% |
| 2008 Q3 | -440.00 USD | -105.72% |
| 2008 FY | 130.74 Thousand USD | 3039.43% |
| 2007 FY | -4448.00 USD | 67.74% |
| 2007 Q4 | -4448.00 USD | 0.0% |
| 2006 FY | -13.78 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 68.794% |
| BrainsWay Ltd. | -10.32 Million USD | 181.891% |
| Cerus Corporation | 84.35 Million USD | 89.981% |
| Envoy Medical, Inc. | -3.81 Million USD | 321.582% |
| electroCore, Inc. | -9.95 Million USD | 184.893% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 264.9% |
| IceCure Medical Ltd | -9.93 Million USD | 185.073% |
| Inogen, Inc. | -103.56 Million USD | 108.16% |
| OrthoPediatrics Corp. | -9.26 Million USD | 191.196% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 332.11% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 164.527% |
| MaxCyte, Inc. | -27.76 Million USD | 130.44% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 264.48% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 1567.805% |
| Orthofix Medical Inc. | 96.44 Million USD | 91.237% |
| PAVmed Inc | 29.08 Million USD | 70.944% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 149.892% |
| RxSight, Inc. | -6.68 Million USD | 226.514% |
| Sight Sciences, Inc. | -102.71 Million USD | 108.228% |
| SI-BONE, Inc. | 5.72 Million USD | -47.721% |
| TELA Bio, Inc. | -3.94 Million USD | 314.007% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 85.256% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -2300.891% |
| Acutus Medical, Inc. | 12.27 Million USD | 31.174% |
| Talis Biomedical Corporation | -57.06 Million USD | 114.81% |
| Spectral AI, Inc. | -3.5 Million USD | 341.392% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 117.597% |
| CVRx, Inc. | -59.95 Million USD | 114.096% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | -325.933% |
| PetVivo Holdings, Inc. | 1.27 Million USD | -561.466% |
| Bioventus Inc. | 372.51 Million USD | 97.731% |
| Venus Concept Inc. | 74.3 Million USD | 88.626% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 183.001% |
| LivaNova PLC | 62.53 Million USD | 86.485% |
| 908 Devices Inc. | -115.09 Million USD | 107.343% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 97.365% |
| Nemaura Medical Inc. | 9.92 Million USD | 14.85% |
| NeuroPace, Inc. | 54.33 Million USD | 84.447% |
| LENSAR, Inc. | -18.31 Million USD | 146.151% |
| Apyx Medical Corporation | -5.15 Million USD | 264.068% |
| Cutera, Inc. | 288.3 Million USD | 97.069% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | -12.457% |
| BioSig Technologies, Inc. | 262 Thousand USD | -3125.625% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 119.282% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 191.87% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 99.399% |
| Axonics, Inc. | -77.19 Million USD | 110.948% |
| Outset Medical, Inc. | 67.67 Million USD | 87.513% |
| IRIDEX Corporation | -4.28 Million USD | 297.088% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 104.747% |
| IRadimed Corporation | -47.71 Million USD | 117.71% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 379.284% |
| Telesis Bio, Inc. | 32.63 Million USD | 74.104% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 437.757% |
| Varex Imaging Corporation | 316.9 Million USD | 97.333% |
| Quipt Home Medical Corp. | 81.73 Million USD | 89.66% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 403.779% |
| Pulmonx Corporation | -42.36 Million USD | 119.951% |
| Dynatronics Corporation | 6.2 Million USD | -36.22% |
| Modular Medical, Inc. | -8.04 Million USD | 205.088% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 296.675% |
| Semler Scientific, Inc. | -57.13 Million USD | 114.793% |
| InMode Ltd. | -135.39 Million USD | 106.242% |
| Bruker Corporation | 891.3 Million USD | 99.052% |
| Cytosorbents Corporation | 4.18 Million USD | -102.083% |
| DexCom, Inc. | 2.02 Billion USD | 99.583% |
| Align Technology, Inc. | -840.47 Million USD | 101.006% |
| Viveve Medical, Inc. | -13.81 Million USD | 161.182% |
| ZimVie Inc. | 450.41 Million USD | 98.124% |
| Movano Inc. | -5.86 Million USD | 244.07% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 106.285% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 1567.805% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | -325.933% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 97.631% |
| Profound Medical Corp. | -18.17 Million USD | 146.49% |
| Insulet Corporation | 798.1 Million USD | 98.941% |
| enVVeno Medical Corporation | -2.21 Million USD | 481.025% |
| Surmodics, Inc. | -12.01 Million USD | 170.344% |
| iCAD, Inc. | -21.2 Million USD | 139.847% |
| Nuwellis, Inc. | -2.81 Million USD | 399.792% |
| Biotricity, Inc. | 23.09 Million USD | 63.403% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 90.976% |
| Aethlon Medical, Inc. | -4.5 Million USD | 287.734% |
| InspireMD, Inc. | -8.04 Million USD | 205.048% |
| PAVmed Inc. | 29.08 Million USD | 70.944% |
| BIOLASE, Inc. | 11.34 Million USD | 25.501% |
| Beyond Air, Inc. | 6.22 Million USD | -35.674% |
| FONAR Corporation | -14.66 Million USD | 157.627% |
| AxoGen, Inc. | 32.26 Million USD | 73.808% |
| Vivani Medical, Inc. | 42 Thousand USD | -20021.755% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 179.294% |
| Inari Medical, Inc. | -7.16 Million USD | 218.016% |
| UFP Technologies, Inc. | 40.77 Million USD | 79.273% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | -175.405% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 277.124% |
| Tenon Medical, Inc. | -1.25 Million USD | 773.397% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 211.111% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 170.861% |
| AdaptHealth Corp. | 2.21 Billion USD | 99.619% |
| Sintx Technologies, Inc. | 905 Thousand USD | -833.827% |
| NanoVibronix, Inc. | -3.27 Million USD | 357.814% |
| Quanterix Corporation | -132.95 Million USD | 106.356% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 403.779% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 137.787% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 98.879% |
| TransMedics Group, Inc. | 121.13 Million USD | 93.023% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 132.281% |
| NeuroMetrix, Inc. | -1.49 Million USD | 666.783% |
| Hyperfine, Inc. | -75.61 Million USD | 111.176% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 94.447% |
| Biomerica, Inc. | -3.38 Million USD | 349.664% |
| Bone Biologics Corporation | -3.02 Million USD | 379.232% |
| AVITA Medical, Inc. | -26.23 Million USD | 132.217% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 559.698% |
| Silk Road Medical, Inc | 64.42 Million USD | 86.882% |